AU7627496A - Glycine derivatives - Google Patents

Glycine derivatives

Info

Publication number
AU7627496A
AU7627496A AU76274/96A AU7627496A AU7627496A AU 7627496 A AU7627496 A AU 7627496A AU 76274/96 A AU76274/96 A AU 76274/96A AU 7627496 A AU7627496 A AU 7627496A AU 7627496 A AU7627496 A AU 7627496A
Authority
AU
Australia
Prior art keywords
glycine derivatives
glycine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76274/96A
Inventor
Manuel Koller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG, Novartis AG filed Critical Ciba Geigy AG
Publication of AU7627496A publication Critical patent/AU7627496A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU76274/96A 1995-11-17 1996-11-18 Glycine derivatives Abandoned AU7627496A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT95/A02383 1995-11-17
IT95MI002383A IT1276153B1 (en) 1995-11-17 1995-11-17 GLYCINE DERIVATIVES WITH ANTAGONIST ACTIVITY OF METABOTROPIC GLUTAMATE RECEPTORS
PCT/EP1996/005079 WO1997019049A1 (en) 1995-11-17 1996-11-18 Glycine derivatives

Publications (1)

Publication Number Publication Date
AU7627496A true AU7627496A (en) 1997-06-11

Family

ID=11372550

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76274/96A Abandoned AU7627496A (en) 1995-11-17 1996-11-18 Glycine derivatives

Country Status (3)

Country Link
AU (1) AU7627496A (en)
IT (1) IT1276153B1 (en)
WO (1) WO1997019049A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2131463B1 (en) * 1997-04-08 2000-03-01 Lilly Sa DERIVATIVES OF CYCLOPROPYLGLYCIN WITH PHARMACEUTICAL PROPERTIES.
TW544448B (en) 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
JP2002512214A (en) * 1998-04-17 2002-04-23 ケネス カリー， Cuban derivatives as metabolite-producing glutamate receptor antagonists and their preparation process
WO2000075101A1 (en) 1999-06-03 2000-12-14 Lilly, S.A. Excitatory amino acid receptor modulators
ATE287871T1 (en) 1999-06-03 2005-02-15 Lilly Sa MODULATORS OF STIMULATABLE AMINO ACID RECEPTORS
AU2001269821A1 (en) 2000-06-15 2001-12-24 Barbara Chen Cycloalkyl alkanoic acids as integrin receptor antagonists
WO2006087169A1 (en) * 2005-02-15 2006-08-24 Glaxo Group Limited Compounds which potentiate glutamate receptor and uses thereof in medicine
JP2009506069A (en) 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド Neurogenesis through modulation of muscarinic receptors
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
CA2625153A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2377531A2 (en) 2006-05-09 2011-10-19 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1305177C (en) * 1987-06-30 1992-07-14 Yasufumi Ohfune Carboxycyclopropylglycine and process for producing the same
JP2757960B2 (en) * 1988-10-17 1998-05-25 サントリー株式会社 (2R, 3S, 4S) -α- (carboxycyclopropyl) glycine
JPH03261748A (en) * 1990-03-09 1991-11-21 Suntory Ltd 3'-position substituted l-2(carboxycyclopropyl)glycines and production thereof
DE69210214T2 (en) * 1991-10-18 1996-10-02 Suntory Ltd 2- (2,3-DICARBOXYCYCLOPROPYL) GLYCINE AND A METHOD FOR THE PRODUCTION THEREOF
JP3481975B2 (en) * 1992-09-08 2003-12-22 サントリー株式会社 (2S, 1'S, 2'R) -2- (2-carboxy-3-substituted oxymethylcyclopropyl) glycine and process for producing the same

Also Published As

Publication number Publication date
IT1276153B1 (en) 1997-10-27
ITMI952383A0 (en) 1995-11-17
ITMI952383A1 (en) 1997-05-17
WO1997019049A1 (en) 1997-05-29

Similar Documents

Publication Publication Date Title
AU4665596A (en) Pyrazolylbenzoyl derivatives
AU4780896A (en) Core-board
AU7626596A (en) Oxymethoxy-3-aryl-pyrone derivatives
AU4086296A (en) Indolepiperidine derivatives
AU1195897A (en) Heteroarylcarboxamide derivatives
AU1030997A (en) Taphane
AU7053296A (en) Purin-6-one derivatives
AU4875296A (en) Isoxazolyl-benzoyl derivatives
AU5763596A (en) 2-ureido-benzamide derivatives
AU7627496A (en) Glycine derivatives
AU6191796A (en) Sulfonyl- or sulfinylbenzoylguanidine derivatives
AU7292196A (en) Cyclopeptide derivatives
AU7084796A (en) Diarylalkenylamine derivatives
AU5593896A (en) Benzisothiazolyl-substituted aminomethylchromans
AU5052296A (en) 4-indolylpiperazinyl derivatives
AU4547796A (en) Hexahydropyrazinoquinoline derivatives
AU4382896A (en) Acetylimidazobenzodiazepines
AU4211296A (en) 4-aminobenzoylguanidine derivatives
AU6929696A (en) Pyrazol-4-ylbenzoyl derivatives
AU4547396A (en) Thioquinoline derivatives
AU6890696A (en) Peptide derivatives
AU6214896A (en) Alkenyl-benzoylguanidine derivatives
AU6890596A (en) Peptide derivatives
AU4220096A (en) 4-mercaptobenzoylguanidine derivatives
AU4547496A (en) 5-aminoflavone derivatives